EQPGX
Price
$26.24
Change
-$0.16 (-0.61%)
Updated
Sep 25 closing price
Net Assets
12.59B
GFACX
Price
$74.20
Change
-$0.72 (-0.96%)
Updated
Sep 25 closing price
Net Assets
338.37B
Interact to see
Advertisement

EQPGX vs GFACX

Header iconEQPGX vs GFACX Comparison
Open Charts EQPGX vs GFACXBanner chart's image
Fidelity Advisor Equity Growth I
Price$26.24
Change-$0.16 (-0.61%)
VolumeN/A
Net Assets12.59B
American Funds Growth Fund of Amer C
Price$74.20
Change-$0.72 (-0.96%)
VolumeN/A
Net Assets338.37B
EQPGX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQPGX vs. GFACX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQPGX is a Hold and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. EQPGX (12.6B). EQPGX (0.00) and GFACX (0.00) have matching dividends . EQPGX was incepted earlier than GFACX: EQPGX (42 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than EQPGX (0.67). EQPGX is a more actively managed with annual turnover of: 52.00 vs. GFACX (25.00). EQPGX has a lower initial minimum investment than GFACX: EQPGX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.71 vs. EQPGX (5.10). EQPGX return over 5 years is better than : 53.04 vs. GFACX (37.51).
EQPGXGFACXEQPGX / GFACX
Total Expense Ratio0.671.3649%
Annual Report Gross Expense Ratio0.671.3649%
Fund Existence42 years25 years-
Gain YTD13.11116.37480%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets12.6B338B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.1010.7148%
Returns for 3 years81.0765.29124%
Returns for 5 years53.0437.51141%
Returns for 10 years174.0393.03187%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.840.43
+17.84%
CytomX Therapeutics
EPAC39.71-0.75
-1.85%
Enerpac Tool Group Corp
SOLV70.46-1.36
-1.89%
Solventum Corp
BAOS3.26-0.09
-2.69%
Baosheng Media Group Holdings Limited
YTRA1.42-0.08
-5.63%
Yatra Online